Crescent Park Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.12M Sell
570,232
-113,179
-17% -$1.81M 3.51% 12
2025
Q1
$13.3M Sell
683,411
-1,179,071
-63% -$22.9M 6.19% 5
2024
Q4
$41M Buy
1,862,482
+142,534
+8% +$3.14M 15.71% 2
2024
Q3
$29M Buy
1,719,948
+1,667,994
+3,211% +$28.1M 11.53% 2
2024
Q2
$621K Hold
51,954
0.29% 18
2024
Q1
$576K Sell
51,954
-274,624
-84% -$3.04M 0.22% 20
2023
Q4
$2.83M Buy
326,578
+27,329
+9% +$237K 0.61% 20
2023
Q3
$2.29M Buy
299,249
+18,685
+7% +$143K 0.54% 22
2023
Q2
$2.02M Buy
280,564
+25,451
+10% +$183K 0.59% 21
2023
Q1
$1.55M Sell
255,113
-113,695
-31% -$692K 0.51% 21
2022
Q4
$1.61M Sell
368,808
-260,921
-41% -$1.14M 0.51% 20
2022
Q3
$2.47M Buy
629,729
+28,192
+5% +$111K 0.59% 24
2022
Q2
$3.07M Buy
601,537
+14,633
+2% +$74.6K 0.66% 25
2022
Q1
$3.76M Sell
586,904
-403,266
-41% -$2.58M 0.61% 27
2021
Q4
$7.94M Sell
990,170
-112,307
-10% -$901K 1.29% 23
2021
Q3
$10.2M Buy
+1,102,477
New +$10.2M 1.5% 25